Found 14 results
Author [ Title(Asc)] Type Year
Filters: Author is Graham, B  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
S
L. Chang, Dowd, K., Mendoza, F., Saunders, J., Sitar, S., Plummer, S., Yamshchikov, G., Sarwar, U., Hu, Z., Enama, M., Bailer, R., Koup, R., Schwartz, R., Akahata, W., Nabel, G., Mascola, J., Pierson, T., Graham, B., and Ledgerwood, J., Safety and Tolerability of Chikungunya Virus-Like Particle Vaccine in Healthy Adults: A Phase 1 Dose-Escalation Trial, Lancet, vol. 384, no. 9959, pp. 2046-2052, 2014.
W. Jaoko, Karita, E., Kayitenkore, K., Omosa-Manyonyi, G., Allen, S., Than, S., Adams, E., Graham, B., Koup, R., Bailer, R., Smith, C., Dally, L., Farah, B., Anzala, O., Muvunyi, C., Bizimana, J., Tarragona-Fiol, T., Bergin, P., Hayes, P., Ho, M., Loughran, K., and Komaroff, W., Safety and Immunogenicity Study of Multiclade HIV-1 Adeno-Viral Vector Vaccine Alone or as Boost Following a Multiclade HIV-1 DNA Vaccine in Africa, PLoS ONE, vol. 5, p. e12873, 2010.
W. Jaoko, Kayitenkore, K., G Manyonyi, O., Karita, E., Schmidt, C., Fast, P., Komaroff, W., Cooper, A., Boaz, M., Gilmour, J., Dally, L., Ho, M., Smith, C., and Graham, B., Safety and Immunogenicity of VRC Multiclade HIV-1 Adenoviral Vector Vaccine Alone or with VRC Multiclade HIV-1 DNA Plasmid Vaccine in the African Adults, in AIDS Vaccine 2007 Conference, Seattle, WA, 2007.
U. Sarwar, Costner, P., Enama, M., Berkowitz, N., Hu, Z., Hendel, C., Sitar, S., Plummer, S., Mulangu, S., Bailer, R., Koup, R., Mascola, J., Nabel, G., Sullivan, N., Graham, B., and Ledgerwood, J. E., Safety and Immunogenicity of DNA Vaccines Encoding Ebolavirus and Marburgvirus Wild-Type Glycoproteins in a Phase I Clinical Trial, J Infect Dis, vol. 211, no. 4, pp. 549-557, 2015.
P
R. Seder, Chang, L., Enama, M., Zephir, K., Sarwar, U. N., Gordon, I., Holman, L., James, E., Billingsley, P., Gunasekera, A., Richman, A., Chakravarty, S., Manoj, A., Velmurugan, S., Li, M., Ruben, A., Sim, B., Li, T., Eappen, A., Stafford, R., Plummer, S., Hendel, C., Novik, L., Costner, P., Mendoza, F., Saunders, J., Nason, M., Richardson, J., Murphy, J., Davidson, S., Richie, T., Sedegah, M., Sutamihardja, A., Fahle, G., Lyke, K., Laurens, M., Roederer, M., Tewari, K., Epstein, J., Ledgerwood, J., Graham, B., and Hoffman, S., Protection Against Malaria by Intravenous Immunization With A Non-Replicating Sporozoite Vaccine, Science, vol. 341, pp. 1359-1365, 2013.
R. Belshe, Bolognesi, D., Clements, M., Corey, L., Fast, P., Graham, B., Keefer, M., Mestecky, J., Mulligan, M., and Stablein, D., Progress in HIV-1 Vaccine Development, in 2nd National Conference on Human Retroviruses and Related Infections, Washington DC, 1995.
M. Crank, Gordon, I., Yamshchikov, G., Sitar, S., Hu, Z., Enama, M., Holman, L., Bailer, R., Pearce, M., Koup, R., Mascola, J., Nabel, G., Tumpey, T., Schwartz, R., Graham, B., and Ledgerwood, J., Phase 1 Study of Pandemic H1 DNA Vaccine in Healthy Adults, PLoS One, vol. 10, no. 4, p. e0123969, 2015.
A. T. Catanzaro, Koup, R. A., Roederer, M., Bailer, R. T., Enama, M. E., Moodie, Z., Gu, L., Martin, J. E., Novik, L., Chakrabarti, B. K., Butman, B., Gall, J., King, C., Andrews, C., Sheets, R., Gomez, P., Mascola, J., Nabel, G., Graham, B., and Team, T. Vaccine Re, Phase 1 Safety and Immunogenicity Evaluation of a Multiclade HIV-1 Candidate Vaccine Delivered by a Replication-Defective Recombinant Adenovirus Vector, J Infect Dis, vol. 194, pp. 1638-1649, 2006.